Skip to main content Accessibility help
×
Hostname: page-component-74656f9884-7drmj Total loading time: 0 Render date: 2026-11-05T07:41:05.219Z Has data issue: false hasContentIssue false
This chapter is part of a book that is no longer available to purchase from Cambridge Core

6 - Dementia and Its Treatment

Stephen M. Stahl
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Harold, a 74-year-old patient, is brought to your office by his daughter, who reports that her father has been exhibiting several concerning symptoms over the past year. Comprehensive questioning reveals that his symptoms are: trouble remembering familiar things, such as telephone numbers commonly dialed; not recognizing some close family members who visit often; and difficulty performing writing tasks. The patient’s motor function appears to be unaffected. Although not definitive, these symptoms are most likely indicative of which type of dementia?

Information

Type
Chapter
Information
Stahl's Self-Assessment Examination in Psychiatry
Multiple Choice Questions for Clinicians
 , pp. 179 - 206
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 12)CrossRefGoogle Scholar
Stahl, SM, Morrissette, DA. Stahl’s illustrated Alzheimer’s disease and other dementias. New York, NY: Cambridge University Press; 2018.Google Scholar

References

Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 12)CrossRefGoogle Scholar
Woolf, NJ, Butcher, LL. Cholinergic systems mediate action from movement to higher consciousness. Behav Brain Res 2011;221(2):488–98.CrossRefGoogle ScholarPubMed

References

Barnes, DE, Yaffe, K, Byers, AL et al. Midlife versus late-life depressive symptoms and risk of dementia: differential effects for Alzheimer’s disease and vascular dementia. Arch Gen Psychiatry 2012;69(5):493–8.Google Scholar
Pomara, N, Bruno, D, Sarreal, AS et al. Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry 2012;169:523–30.CrossRefGoogle ScholarPubMed
Stahl, SM, Morrissette, DA. Stahl’s illustrated Alzheimer’s disease and other dementias. New York, NY: Cambridge University Press; 2018.Google Scholar

References

Atwood, CS, Bishop, GM, Perry, G et al. Amyloid beta: a vascular sealant that protects against hemorrhage? J Neurosci Res 2002;70(3):356.CrossRefGoogle ScholarPubMed
Kokjohn, TA, Maarfouf, CL, Roher, AE. Is Alzheimer’s disease amyloidosis the result of a repair mechanism gone astray? Alzheimers Dement 2012;8(6):574–83.Google Scholar
Kumar, DK, Choi, SH, Washicosky, KJ et al. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med 2016;8(340):340ra72.CrossRefGoogle ScholarPubMed
Stahl, SM, Morrissette, DA. Stahl’s illustrated Alzheimer’s disease and other dementias. New York, NY: Cambridge University Press; 2018.Google Scholar

References

Stahl, SM. Stahl’s essential psychopharmacology, the prescriber’s guide, seventh edition. New York, NY: Cambridge University Press; 2020.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 12)Google Scholar

References

Kotermanski, SE, Johnson, JW. Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer’s drug memantine. J Neurosci 2009;29(9):2774–9.Google Scholar
Stahl, SM. Stahl’s essential psychopharmacology, fifth edition. New York, NY: Cambridge University Press; 2021. (Chapter 12)CrossRefGoogle Scholar
Stahl, SM, Morrissette, DA. Stahl’s illustrated Alzheimer’s disease and other dementias. New York, NY: Cambridge University Press; 2018.CrossRefGoogle Scholar

References

Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 2016;12(4):459–509.CrossRefGoogle Scholar
Godyń, J, Jończyk, J, Panek, D et al. Therapeutic strategies for Alzheimer’s disease in clinical trials. Pharmacol Rep 2016;68:127–38.CrossRefGoogle ScholarPubMed
Harrison, JR, Owen, MJ. Alzheimer’s disease: the amyloid hypothesis on trial. Br J Psychiatry 2016;208(1):1–3.CrossRefGoogle ScholarPubMed
Panza, F, Seripa, D, Solfrizzi, V et al. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients. Expert Opin Emerg Drugs 2016;21(4):377–91.CrossRefGoogle ScholarPubMed
Pedersen, JT, Sigurdsson, EM. Tau immunotherapy for Alzheimer’s disease. Trends Mol Med 2015;21(6):394–402.CrossRefGoogle ScholarPubMed

References

Giri, M, Zhang, M, Lu, Y. Genes associated with Alzheimer’s disease: an overview and current status. Clin Interv Aging 2016;11:665–81.Google Scholar
Hinz, FI, Geschwind, DH. Molecular genetics of neurodegenerative dementias. Cold Spring Harb Perspect Biol 2017;9(4):a023705.Google Scholar
Rosenberg, RN, Lambracht-Washington, D, Yu, G et al. Genomics of Alzheimer disease: a review. JAMA Neurol 2016;73(7):867–74.CrossRefGoogle ScholarPubMed
Schellenberg, GD, Montine, TJ. The genetics and neuropathology of Alzheimer’s disease. Acta Neuropathol 2012;124(3):305–23.CrossRefGoogle ScholarPubMed

Reference

Stahl, SM, Morrissette, DA. Stahl’s illustrated Alzheimer’s disease and other dementias. New York, NY: Cambridge University Press; 2018.Google Scholar

Reference

McKhann, GM, Knopman, DS, Chertkow, H et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7(3):263–9.CrossRefGoogle ScholarPubMed

References

Ford, AH. Preventing delirium in dementia: managing risk factors. Maturitas 2016;92:35–40.Google Scholar
Lippmann, S, Perugula, ML. Delirium or dementia? Innov Clin Neurosci 2016;13(9–10):56–7.Google Scholar

Reference

Stahl, SM, Morrissette, DA. Stahl’s illustrated Alzheimer’s disease and other dementias. New York, NY: Cambridge University Press; 2018.CrossRefGoogle Scholar

Reference

Hodgson, NA, Gitlin, LN, Winter, L et al. Undiagnosed illness and neuropsychiatric behaviors in community residing older adults with dementia. Alzheimer Dis Assoc Disord 2011;25:109–15.Google Scholar

References

Canevelli, M, Valleta, M, Trebbastoni, A et al. Sundowning in dementia: clinical relevance, pathophysiological determinants, and therapeutic approaches. Front Med (Lausanne) 2016;3:73.Google Scholar
Satlin, A, Volicer, L, Ross, V et al. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer’s disease. Am J Psychiatry 1992;149(8):1028–32.Google ScholarPubMed
Skjerve, A, Nygaard, HA. Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil. Int J Geriatr Psychiatry 2000;15(12):1147–51.Google Scholar
Stahl, SM, Morrissette, DA. Stahl’s illustrated Alzheimer’s disease and other dementias. New York, NY: Cambridge University Press; 2018.Google Scholar

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Dementia and Its Treatment
  • Stephen M. Stahl, University of California, San Diego
  • Book: Stahl's Self-Assessment Examination in Psychiatry
  • Online publication: 22 July 2022
  • Chapter DOI: https://doi.org/10.1017/9781009241595.008
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Dementia and Its Treatment
  • Stephen M. Stahl, University of California, San Diego
  • Book: Stahl's Self-Assessment Examination in Psychiatry
  • Online publication: 22 July 2022
  • Chapter DOI: https://doi.org/10.1017/9781009241595.008
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Dementia and Its Treatment
  • Stephen M. Stahl, University of California, San Diego
  • Book: Stahl's Self-Assessment Examination in Psychiatry
  • Online publication: 22 July 2022
  • Chapter DOI: https://doi.org/10.1017/9781009241595.008
Available formats
×